Citations 2

Randomized, phase III trial of the efficacy and safety of lenalidomide plus R-CHOP vs R-CHOP in patients with untreated ABC-type diffuse large B-cell lymphoma.

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: TPS8600-TPS8600

10.1200/jco.2015.33.15_suppl.tps8600

ROBUST: Lenalidomide-R-Chop Versus Placebo-R-Chop in Previously Untreated Abc-Type Diffuse Large B-Cell Lymphoma

Future Oncology | April 18, 2016 | Volume: 12 | Issue: 13 | Pages: 1553-1563

10.2217/fon-2016-0130 | PMID 27089170